Posts

Showing posts from July, 2022

Non-Invasive Prenatal Testing (NIPT) Market is estimated to be 11.8 Billion by 2029 with a CAGR of 11.9% during the forecasted period.

Image
A Non-Invasive Prenatal Testing (NIPT)   is a screening test to identify if the unborn child/fetus is at risk for a number of genetic disorders like Down syndrome, Edwards syndrome, Patau syndrome, etc. The test is done by using blood sample thus reducing the risk of miscarriage during testing to absolute nil coupled with the ability to screen for a number of disorders within 10 weeks in pregnancy, much earlier as compared to any other prenatal diagnostic tests. NIPT has been ranked as the most successful, sensitive and the most accurate test thereby being the mostly preferred test. The global non-invasive prenatal testing (NIPT) market accounted for US$ 4.3  billion in 2019 and is estimated to be US$ 11.8 billion by 2029 and is anticipated to register a CAGR of 11.9%. The report " Global Non-Invasive Prenatal Testing (NIPT) Market, By Product Type (Devices, Consumables, and Others), By Techniques (cfDNA, Biochemical Screening Tests, and Ultrasound Detection), By Application (Tris

Patient Infotainment Terminals Market accounted for US$ 512.5 million in 2019 and is estimated to be US$ 1337.5 million by 2029 and is anticipated to register a CAGR of 10.1%

Image
  Patient infotainment  is a bedside terminal allowing multimedia entertainment and communication choices. Patient infotainment terminal also helps medical staff by providing secure access to electronic patient data remotely with an enhanced hospital workflow as a professional diagnosis support. Patient infotainment terminals are fortified with a 15.6" or 17” multi-function touchscreen, RFID, Wi-Fi, handset, smart card reader and 2 megapixel camera. It deliver patients with multiple entertainment programs such as TV, computer games or movies because of Microsoft Windows and Intel processor. The global patient infotainment terminals market accounted for US$ 512.5 million in 2019 and is estimated to be US$ 1337.5 million by 2029 and is anticipated to register a CAGR of 10.1%. The report " Global Patient Infotainment Terminals Market, By Type (Small Size (Less than or Equal to 12.5"), Medium Size (12.5" to 19.5"), and Large Size (Greater-Than 19.5")), By En

Systemic Lupus Erythematosus Market accounted for US$ 1.87 billion in 2019 and is estimated to be US$ 3.6 billion by 2029 and is anticipated to register a CAGR of 7.0%

Image
  Systemic Lupus Erythematosus (SLE) is the chronic, autoimmune disorder which involves several organ-systems such as kidney, heart, blood, skin, joints, and lungs in most severe cases, brain. In this disease, the human immune system converts hyperactive and attacks the healthy, normal tissues of the body. SLE can often result in symptoms such as malar rash, sub-acute cutaneous lesions, discoid lesions, arthritis, photosensitivity, oral ulcers, serositis, nephropathy, thrombocytopenia, haemolytic anemia, neurologic involvement, fever, thrombosis, Raynaud’s phenomenon, livedo reticularis, and myositis. The global systemic lupus erythematosus market accounted for US$ 1.87 billion in 2019 and is estimated to be US$ 3.6 billion by 2029 and is anticipated to register a CAGR of 7.0%. The report  " Global   Systemic Lupus Erythematosus Market, By Drug Classes (NSAIDs, Corticosteroids, Antimalarials, Immunosuppressants, and Biologics), By Route of Administration (Oral, Intravenous, and

Blood Glucose Monitoring Market is estimated to be 19.6 Billion by 2029 with a CAGR of 6.6% during the forecasted period.

Image
Blood glucose monitoring   is the process of testing the diabetes level within the blood. It helps to acknowledge the glucose level of blood within the required target range. Blood sugar monitoring devices provide useful insight to manage diabetes. It helps to trace the progress of treatment goal also as observe the effect of medication on blood glucose level and understand how ailment affects the glucose level within the blood. The global blood glucose monitoring market accounted for US$ 11.10 billion in 2020 and is estimated to be US$ 19.6 billion by 2029 and is anticipated to register a CAGR of 6.6. The report " Global Blood Glucose Monitoring Market, By Type ( Self-Monitoring Blood Glucose and Continuous Blood Glucose Monitoring ), By Component ( Glucometer Devices, Test Strips, Lancets, Sensors, and Receivers ) ,  and By Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Trends, Analysis and Forecast till 2029” . Key Highlights: In

Mental Health Market is estimated to be US$ 527.44 billion by 2030 with a CAGR of 3.40% during the forecast period

Image
Dynamic internal equilibrium that enables people to make use of their talents in accordance with the common values of society is referred to as   M ental Health .   It aids in developing empathy for others, expressing and controlling one's own emotions, and dealing with difficult life circumstances. Additionally, it helps with social role-playing and preserving a healthy connection between the body and the mind. However, its imbalance can result in bipolar illness, depression, and anxiety. It may also result in physical discomfort across the body, including the head, back, and stomach. The market is growing as a result of an increase in the prevalence of mental diseases, an increase in the elderly population, and an expansion of awareness campaigns for mental health. The global market for mental health is also expanding as a result of increased education about mental diseases, advocacy work for more human rights respect, and efforts to reduce stigma. However, it is anticipated that